Alexander Everhart

Also affiliated with Center for Advancing Health

Economics, Econometrics and FinanceHealth ProfessionsMedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm”.

Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm

International Journal of Health Economics and Management(2020)10.1007/s10754-020-09282-2

N/A

0DataRank · unranked

5 citations

Nihar R. Desai, Bryan Dowd, Alexander Everhart, Jeph Herrin, Lucas Higuera +6 more

Physician Network Connections Associated With Faster De-Adoption of Dronedarone for Permanent Atrial Fibrillation

Circulation Cardiovascular Quality and Outcomes(2021)10.1161/circoutcomes.121.008040

N/A

0DataRank · unranked

2 citations

Alexander Everhart, Laura Barrie Smith, Anupam B. Jena, Joseph S. Ross, Nihar R. Desai +3 more

Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after TREAT trial showed they are ineffective and unsafe

Research Square(2021)10.21203/rs.3.rs-329817/v1

N/A

0DataRank · unranked

0 citations

Jiani Zhou, Alexander Everhart, Nihar R. Desai, Jeph Herrin, Anupam B. Jena +4 more

Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after the TREAT trial

BMC Nephrology(2021)10.1186/s12882-021-02491-y

N/A

0DataRank · unranked

0 citations

Jiani Zhou, Alexander Everhart, Nihar R. Desai, Jeph Herrin, Anupam B. Jena +4 more

Trends in Osteoporosis Drug Therapy Receipt Among Commercial and Medicare Advantage Enrollees in the United States, 2011-2022

The Journal of Clinical Endocrinology & Metabolism(2025)10.1210/clinem/dgae840

N/A

0DataRank · unranked

9 citations

Juan P. Brito, B.L. Clarke, Jeph Herrin, Pinar Karaca‐Mandic, Kurt A. Kennel +5 more